IFNA17 and systemic lupus erythematosus: The presence of elevated serum levels of IFN-α ranged from 5% to 70% of SLE patients [10,11], the lower prevalence possibly arose from factors affecting their detection by ELISA such as blocking or auto-antibody interactions.